Park et al. suggested a strategy to control paracrine proteins and signaling pathways in adipose-derived stem cells (ADSCs) to attract CD8+ CTLs to melanoma, allowing for effective tumor immunotherapy [55]. Here, CD8A is linked to melanoma.